Cargando…
Production of Single-Chain Fv Antibodies Specific for GA-Pyridine, an Advanced Glycation End-Product (AGE), with Reduced Inter-Domain Motion
Due to their lower production cost compared with monoclonal antibodies, single-chain variable fragments (scFvs) have potential for use in several applications, such as for diagnosis and treatment of a range of diseases, and as sensor elements. However, the usefulness of scFvs is limited by inhomogen...
Autores principales: | Fukuda, Natsuki, Noi, Kentaro, Weng, Lidong, Kobashigawa, Yoshihiro, Miyazaki, Hiromi, Wakeyama, Yukari, Takaki, Michiyo, Nakahara, Yusuke, Tatsuno, Yuka, Uchida-Kamekura, Makiyo, Suwa, Yoshiaki, Sato, Takashi, Ichikawa-Tomikawa, Naoki, Nomizu, Motoyoshi, Fujiwara, Yukio, Ohsaka, Fumina, Saito, Takashi, Maenaka, Katsumi, Kumeta, Hiroyuki, Shinya, Shoko, Kojima, Chojiro, Ogura, Teru, Morioka, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151396/ https://www.ncbi.nlm.nih.gov/pubmed/28994732 http://dx.doi.org/10.3390/molecules22101695 |
Ejemplares similares
-
Cyclization of Single-Chain Fv Antibodies Markedly Suppressed Their Characteristic Aggregation Mediated by Inter-Chain VH-VL Interactions
por: Yamauchi, Soichiro, et al.
Publicado: (2019) -
Molecular Dynamics-Based
Design and Biophysical Evaluation
of Thermostable Single-Chain Fv Antibody Mutants Derived from Pharmaceutical
Antibodies
por: Okazaki, Kyo, et al.
Publicado: (2023) -
Role of microRNAs in the crosstalk between the gut microbiota and intestinal immune system
por: SONOYAMA, Kei, et al.
Publicado: (2023) -
Mixed Peptide-Conjugated Chitosan Matrices as Multi-Receptor Targeted Cell-Adhesive Scaffolds
por: Hozumi, Kentaro, et al.
Publicado: (2018) -
Administration of Bifidobacterium pseudolongum suppresses the increase of colonic serotonin and alleviates symptoms in dextran sodium sulfate-induced colitis in mice
por: TATSUOKA, Misa, et al.
Publicado: (2023)